Popular Japanese Skin Care Brand Arrives in the United States

ORCHARD PARK, N.Y., Sept. 19, 2013 /PRNewswire/ -- The Mentholatum Company, a division of Japan's Rohto Pharmaceutical Co., Ltd., announces the U.S. launch of its best-selling Hada Labo skin care range, Hada Labo Tokyo™ this fall in the U.S.  Hada Labo launched in Japan in 2004 and has experienced significant growth across South East Asia, where a bottle of Clear Liquid Hydrator is sold every 2 seconds.

Hada Labo Tokyo™ is a new generation of lightweight, deeply hydrating, anti-aging skin care promising a beautifully radiant and youthful complexion. The range features Super Hyaluronic Acid™, a powerful proprietary combination of three types of hyaluronic acid for multi-layer, long-lasting moisture to effectively restore and strengthen skin's natural hydrating ability that depletes with age and sun exposure.

Hada Labo Tokyo™ will be among the very few Japanese skin care ranges to launch in the U.S. non-prestige market and is sold at select retailers including all 550 Ulta Stores nationwide and at Drugstore.com; prices range from $11.99-$24.99.

"After extensive consumer research, we have found that the quest for the perfect skin care product is always on women's minds. Hada Labo Tokyo's lightweight and deeply hydrating formulas, which are also free of parabens, fragrance, mineral oil and dyes, are extremely appealing to the U.S. consumer," says Katherine Tocheff, Director of Marketing and Innovation Skin Care and Lip Care, The Mentholatum Company, a division of Rohto Pharmaceutical Co., Ltd.

About Rohto Pharmaceutical Company, Ltd.
Rohto Pharmaceutical Co., Ltd. was founded in 1899 and is now the 2nd largest consumer health company in Japan, establishing its position as a world leader in manufacturing and marketing of pharmaceuticals, cosmetics, skin care and health care products. Rohto has operations in 12 major markets, with distribution in more than 150 countries globally.

About The Mentholatum Company
The Mentholatum Company was founded in 1889, and acquired by Rohto Pharmaceutical Co., Ltd in 1988. The Mentholatum Company has manufacturing plants in five locations around the globe and maintains its focus to provide quality health care solutions for the treatment and prevention of conditions associated with skin care, pain relief and eye care with products that are sold in over 150 countries.

SOURCE The Mentholatum Company